AcroCyte Therapeutics

AcroCyte Therapeutics Inc. is dedicated to overcoming common laboratory challenges. Through our R³CE® (Rapid, Reproducible, Rare Cell 3D Expansion) technology, we have established ourselves as experts in 3D culturing, focused particularly on our industry-leading work with CTC (Circulating Tumor Cell). This groundbreaking technology allows us to successfully culture CTCs from a patient's blood and create personalized 3D cell culture models from virtually any specimen. This innovation eliminates the need for traditional cell lines and animal testing, enabling scientists to conduct research on a platform that is both more authentic and highly efficient. Through our Onco-REAL™ clinical service, we are empowering patients to access truly personalized treatment plans using their own cells.